Natasha B. Leighl, MD, MMSc, FRCP, FASCO Princess Margaret Cancer Center, Toronto 5Live #ASCO20
4:56
Key Insights on CCTG BR.34: A randomized trial of durvalumab and tremelimumab +/- platinum-based chemotherapy in patients with metastatic (Stage IV) squamous or nonsquamous non-small cell lung cancer (NSCLC).
Lung Cancer
Natasha B. Leighl, MD, MMSc, FRCP, FASCO Princess Margaret Cancer Center, Toronto 5Live #ASCO20
Key Insights on CCTG BR.34: A randomized trial of durvalumab and tremelimumab +/- platinum-based chemotherapy in patients with metastatic (Stage IV) squamous or nonsquamous non-small cell lung cancer (NSCLC).
Lung Cancer Similar Videos
Similar Videos
